Co-Diagnostics, Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Co-Diagnostics, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q4 2016 to Q4 2023.
  • Co-Diagnostics, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending December 31, 2023 was $4.04M.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $4.04M Dec 31, 2023 10-K 2024-03-14
Q4 2019 $5.13M +$1.29M +33.6% Dec 31, 2019 10-K 2021-03-25
Q4 2018 $3.84M +$1.3M +51.4% Dec 31, 2018 10-K 2020-03-30
Q4 2017 $2.54M +$986K +63.6% Dec 31, 2017 10-K 2019-04-01
Q4 2016 $1.55M Dec 31, 2016 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.